Changes in biodistribution on (68)Ga-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression

BACKGROUND: To evaluate the effects of long-acting somatostatin analogue (SSA) therapy on (68)Ga-DOTA-octreotate (GaTate) uptake at physiological and metastatic sites in neuroendocrine tumour (NET) patients. METHODS: Twenty-one patients who underwent GaTate PET/CT before and after commencement of SS...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherk, Martin H., Kong, Grace, Hicks, Rodney J., Hofman, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781297/
https://www.ncbi.nlm.nih.gov/pubmed/29361984
http://dx.doi.org/10.1186/s40644-018-0136-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781297/
https://www.ncbi.nlm.nih.gov/pubmed/29361984
http://dx.doi.org/10.1186/s40644-018-0136-x

Ejemplares similares